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A  cluster  of T  cell-specific  alloantigens,  encoded  by genes  linked  to  Igh-1, have 
been  hypothesized  to  be  constant  region  determinants  for T  cell  receptors  in  the 
mouse  (1-4).  Similar  antigens  have been shown to be present  on antigen-specific T 
cell  factors  (5,  6).  It has been shown  that  three  of these structural  products  (Tthy, 
Tind,  and Tsu)  are  distributed  on cells  in  an ordered  sequence  during  maturation 
and  ontogeny  (4).  All  of these  determinants  are,  however,  expressed  on  T  cells 
postnatally and do not appear in the nude animal  (4), a  well-documented source of 
pre-T cells (7). It is known that T  cells can be sensitized to respond to alloantigens in 
an antigen-specific pattern after  14 d  in organ culture  (8)  and that the restriction to 
self-recognition and allorecognition occurs before thymic trafficking (9). We therefore 
conclude that cells must express antigen receptors at the pre-T cell level. This rationale 
led to the search for a pre-T cell antigen receptor. This paper describes an alloantigen 
on prethymic T  cells that is genetically linked in expression to the region proposed to 
be IgT-C. 
Fetal  T  cell  hybrids,  which were negative  for the Tthy, Tind,  and Tsu  antigens, 
were  used  as  a  target  to screen  monoclonal  antibodies  generated  in  outbred  nu/nu 
(Igh-1  a) animals immune to C.AL-20 (Igh-1  a)  17-d fetal thymocytes. This path led to 
the  selection  of F.6.9.1,  a/zk  monoclonal anti-Tpre a.  The alloantigen  recognized  is 
expressed on fetal T  cells, some adult thymocytes, adult bone marrow, and spleen (in 
low frequency or density).  The homozygous nuStr/nuStr  bone marrow is a  rich source 
of this  cell,  in  contrast  to  the  cells  expressing  Tthy,  Tind,  and  Tsu,  which  fail  to 
appear in the nude animal. An arrest in maturation in the nude animal may result in 
failure of this cell to exit from the marrow in high numbers. 
Methods 
Generation of Fetal Thymocyte, Fetal T Liver, and Fetal B Liver Hybrids.  Fetal thymocytes, or fetal 
liver cells, were removed from developing mice by dissection under low-power microscopy. The 
time of gestation was estimated from the morphology of the fetus (10) and from the appearance 
of vaginal plugs. Organs were removed and cells were teased out by pressing between two glass 
slides.  Single-cell  suspensions  were  mixed  with  either  BW5147  (11) or P.3U1  nonsecreting 
myeloma cells (12), pelleted, and fused with polyethylene glycol (PEG)1 as previously described. 
(]|ones were expanded when they covered the bottom of microtiter plates. The frequency of 
* Supported by grant AI 15262 from the National Institutes of Health. 
1 Abbreviations used in this paper: FTL, fetal T cell hybrids from liver; FIT, fetal T cell hybrids from 
thymus; KLH-TNP, keyhole limpet hemocyanin-trinitrophenyl hapten. 
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hybrid cells was low and the success in long-term maintenance was 10% of the primary hybrids, 
largely due to an extensive crisis period of 5  6  wk after appearance  of primary clones.  Lines 
that survived this initial crisis showed vigorous in vitro growth over a  4-too period. 
Generation of +/nu str and nuStr/nuStr h'nes.  Bone marrow from two AKR nuSt~/nu ~tr or two +/ 
nu str animals was removed under sterile conditions and fused with BW5147.  Briefly described, 
5  ×  106  marrow  cells were  incubated  with  5  ×  106  BW5147  (AKR  origin)  hypoxanthine, 
aminopterin,  thymidine  (HAT)-sensitive thymoma cells in a  V-bottomed tube. 0.5 ml of 40% 
PEG in RPMI  (Kocklight Laboratories Ltd, Berkes, England)  was added  to pelleted cells for 
1 rain  at  room  temperature.  Cells  were  resuspended  in  serum-free  RPMI  by  the  dropwise 
addition  of 15  ml over  10-rain,  centrifuged and  washed  once, resuspended,  placed in a  petri 
dish,  and  incubated  overnight  in  complete media.  Cells were  then  plated  in  HAT-selective 
media  (18)  and  plated  at  limiting dilutions  in  microtiter  wells.  Growth-positive  wells were 
expanded  and  tested.  Equal  numbers  of wells (14/300  wells for both nuStr/nuStr  and  +/nu str) 
showed  growth.  Cells were expanded  and  experienced  3- to 4-wk crisis periods before stable 
growth curves were achieved. 
Monoclonal Antibody  Specific for Tpre.  Outbred nu/nu animals, originating from an attempt to 
breed nu/nu onto BALB/cAnN CrIBr (Charles River Breeding Laboratories, Inc., Wilmington, 
MA) were used. These animals differ from BALB/c at multiple loci but share the Tthy  a allele 
at the IgT-C region.  2 Male animals were immunized with C.AL-20  17-d fetal thymocytes (2 X 
106)  i.p.  on  day  14  and  i.v.  in  phosphate-buffered  saline  on  day  3.  Cells were  prepared  in 
phosphate-buffered  saline.  Spleen cells were removed from  the immunized mouse and  fused 
with  P.3U1  cells  (12).  Clones  appeared  on  day  8,  and  tissue  culture  supernatant  fluid  was 
incubated  with five 51Cr-labeled fetal T  cell hybrid  lines, known  to be negative for the Tthy, 
Tind, and Tsu antigens (4). Antibody and complement-mediated lysis was monitored as counts 
per minute of 5~Cr released. 
Positive lines were then screened on  19-d fetal B cell hybrids. Tpre (F.6.9.1,  ap.K antibody- 
secreting line) was negative on 19-d B cell lines, but positive on several T  cell hybrid lines. Line 
F.6.9.1  was selectively subcloned by limiting dilution in two sequential passages and frozen for 
later use. Data in this paper are based on the tissue culture supernatant  from this line. 
Antibody-Mediated  Cytotoxicity.  Antibody  and  selected  rabbit  complement  were  incubated 
with ~ICr-labeled hybrid cell lines in a  two-stage assay  (13),  or, alternatively, cells lysed were 
visually enumerated by eosin dye exclusion (4). Data are expressed in terms of a cytotoxic index 
(the number  of cells killed by antibody  minus those killed by complement  divided by those 
killed by anti-Thyl.2 minus those killed by complement multiplied by  100).  Arithmetic mean 
_  difference from the mean of duplicate determinations is shown. 
Source of Animals.  AKR nuSt~/nuUr animals were obtained from The Jackson Laboratory, Bar 
Harbor, ME (14).  "BALB/c nu/nu" and BALB/c AnNCrBr were purchased from Charles River 
Breeding Laboratories,  Inc.  C.AL-20,  CB.20,  and  BAB/14 animals  have been  bred  at  Tufts 
University since  1978  from  stock originating from  M.  Potter,  National  Institutes  of Health. 
C.B.AL-1  ard  C.B.AL-4 were derived from breeding stock generously donated  by R.  Riblet, 
Center for Cancer Research, Philadelphia, PA. 
Cortisone Treatment  of Animals.  The cortisone treatment of animals has been described (4). 
Thymocyte Repopulation  Studies.  A report by Basch and Kadish (15)  describes repopulation of 
mouse  thymus  in  760-rad-irradiated  animals  by  syngeneic  marrow,  and  we  followed  their 
protocol closely. Briefly described, C.AL-20 5-wk-old males were given 760 rad of whole-body 
irradiation from a  137Cs source.  1 h  after irradiation,  each mouse was intravenously given  1.5 
×  107  bone  marrow  ceils pooled  from  eight  C.AL-20  age-matched  males.  These  cells were 
pretreated with I #g of anti-Thy-l.2 monoclonal (IgM) antibody (16),  1/~g of anti-Tthy (IgM) 
(3), or 1/~g of anti-Tpre (IgM, F.6.9.1).  Mice were killed at  10 d and thymocytes were counted. 
In the experiment we attempted to use complement of the recipient animal in situ. Alternatively, 
it is possible that removal in the spleen of aggregated cells could be the mechanism of depletion, 
since mouse complement is so inefficient in vitro. The survival rate of repopulated groups was 
in  our  open  animal  room.  That  the  rate  was  not  higher  is  possibly  due  to  endemic  viral 
pathogens known to exist in our colony. 
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The  experiments were  executed  by  pretreatment  with  antibody  and  not  antibody and 
complement because our rabbit complement is very toxic to marrow cells in vitro.  Mice (6) 
were treated intravenously in a separate experiment with  100/tl of either anti-Tpre or anti- 
Tthy tissue culture supernatant to ensure that the antibody alone would not deplete the thymus 
of a normal host. The mice used in the experiment were lethally irradiated with 760 rad gamma 
radiation, and control mice had few residual thymocytes. It seems unlikely that the sole target 
of the antibody is the recipient's thymocytes. 
Results 
Distribution  of Products of the  IgT-C  Region  in  Fetal  T  Cell  Hybrids.  The  Tthy  d 
alloantigen is not expressed on fetal T  cell hybrids from 17-d thymus (FTT 17-1, FTT 
17-2, FTT 17-3)  (Table I), as previously reported (4). These lines were used to screen 
for a  T  cell  antigen  that  might  be expressed earlier  in  ontogeny than  Tthy  d.  The 
F.6.9.1  (anti-Tpre)  line  arose  from  a  BALB/cAnNCriBR-related  nu/nu  animal 
(Charles River Breeding Laboratories, Inc.) that had been immunized with 17-d fetal 
thymocytes (see Materials and Methods).  Spleen cells were removed 3 d after a third 
intravenous immunization with 2 ×  105 cells in phosphate-buffered saline and fused 
with  a  nonsecreting  variant  of P.3U1.  Tissue culture  supernatant  from developing 
clones was incubated with 51Cr-labeled FTT 17-1, FTT 17-2, and FTT 17-3. Comple- 
ment-mediated lysis was monitored by 51Cr release. Positive tissue culture supernatants 
were then screened visually for lysis on each of the hybrid lines. Line F.6.9.1 produces 
#K antibody that reacted with many of the fetal T  cell lines but failed to react with 
most of the control B cell hybrids (Table I) initiated from fusion of fetal liver from the 
same animals. One fetal liver T  cell line, FTL 19-5, expressed all of the T  cell antigens 
encoded by IgT-C (Tpre, Tthy, Tind, and Tsu). This unexpected observation is being 
pursued.  Because lines  FTT  17-1,  FTT  17-3,  and FTL  12-4 express Tpre  d (F.6.9.1) 
but  not  Tthy  d (17IIC6), one must conclude  that  Tthy  d and Tpre  d are on separate 
structural products. 
Table II shows a panel of T  cell hybrids constructed by fusion of adult lymph node 
cells with BW5147. Tpre and Tthy were expressed independently in these lines. Two 
lines  expressing Tpre,  SKT~220,  and  SKTq~230,  arose  from peripheral  cell  fusion. 
Fig.  1 shows that high numbers of antigen-activated lymph node cells from the adult 
animal  can  absorb  anti-Tpre.  Therefore,  it  is  not  surprising  that  some cells  from 
antigen-activated node  (Table II) showed Tpre as a  surface determinant.  Lines 240 
and 208 expressed Tthy but failed to express Tpre. One line (245)  showed Tpre and 
Tthy coexpression. The frequency of adult lymph node hybrids expressing Tpre was 
<2% (data not shown). As many as 10% expressed Tthy. Table I! shows only the lines 
that exhibited dual expression, not a complete panel of adult lines. 
Tpre  Is  Expressed  on  Both  Cortisone-sensitive and  Cortisone-resistant Adult  Thymocytes. 
Antibody specific for Tpre (F.6.9.1  hybridoma tissue culture supernatant)  and com- 
plement  lysed  25%  of both  cortisone-resistant  and  cortisone-sensitive  thymocytes 
(Table III). The cell populations  that expressed Tpre and Tthy may have partially 
overlapped, because the simultaneous addition  of anti-Tpre and anti-Tthy did not 
increase the total number of cells lysed (Table IV). 
Tpre  is Encoded by  the  IgT-C  Region  of Chromosome 12.  Strains  of mice  in  which 
defined recombination events in and/or near the immunoglobulin loci on chromosome 
12 occurred are shown in Table V. Thymocytes from each strain were evaluated on 
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TABLE  I 
Expression of Tpre on Fetal T Cell Hybrids * 
Fetal hybrid 
Tpre~  Tthy  Tind  Tsu  Thy-l.2  Lyt-l.2  Lyt-2.2 
T  cell phenotype 
FTT  19-1  -  -  - 
FTT  19-2  +  ---  - 
FTT  19-5  -  -  - 
FTT  19-3  -  -  - 
FTT  19-4  +  --  - 
FTL  19-1  -  -  - 
FTL  19-2  -  -  - 
FTL  19-5  +  +  + 
FTL  19-6  -  -  - 
FTT  17-1  +  -  - 
FTT  17-2  -  -  - 
FTT  17-3  +  -  - 
FTL  17-1 
FTL  17-2 
+ 
+ 
+ 
--  + 
+ 
+ 
-t-  m 
+ 
+  + 
+ 
w 
FTL  12-1  ...... 
FTL  12-2  ...... 
FTL  12-3  +  +  +  +  +  - 
FTL  12-4  +  ..... 
FTL  12-6  ...... 
FBL  19-1  -  -  - 
FBL  19-2  -  -  - 
FBL  19-3  -  +  - 
FBL  19-4  -  -  - 
FBL  19-5  -  -  - 
FBL  19-6  -  -  - 
m 
m 
n 
m 
i 
m 
FBL  12-2  ...... 
FBL  12-3  +  +  +  +  +  - 
FBL  12-4  ...... 
* Surface phenotype was established  by visual observation  of monoclonal antibody 
and complement-mediated lysis and dye exclusion (17). 
:~ Frequencies of positive cells in a  given line varied from  10 to 30%. 
(F.6.9.1)  and  complement-mediated  lysis.  Only  the  C.AL-20  strain  expressed  this 
antigen.  The  recombinations  between  known  genes  shown  in  Table  V  limit  the 
genetic  information  coding  for expression  of Tpre  to  a  short  region  of chromosome  12, 
previously  called  IgT-C  (2).  Because  BALB/c  (Igh-1 a)  and  BAB/14  (Igh-1 b)  do  not 
react  with  anti-Tpre  d, but  presumably  have  this  cell type,  they  must  express  a  different 
allelic  product.  It  is  possible  that  there  are  three  alleles  for  this  antigen.  Studies  by 
Tokuhisa  and  Taniguchi  (5, 6)  suggest  that  BAB/14  may  express  a  different  allele  for 
Tind  or  Tsu  than  does  BALB/c  or  C.AL-20,  which  may  be  true  for Tthy  and  Tpre  as 
well. 
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Hybrid*  Tpre  Tthy  Tind  Tsu 
SKO 220  +  -  - 
SKO 230  +  -  - 
SKO 245  +  +  + 
SKO 240.6  -  +  + 
SKO 240  -  +  + 
SKO 208  -  +  + 
R 
* The cell lines shown in this panel were generated from fusion of aduh lymph 
node from KLH-TNP footpad-challenged mice with BW5147 (S. K. Keesee, 
unpublished data). 
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TABLE  II 
Expression of Tthy or Tpre on Adult T Cell Hybrids 
Fie.  1.  Adsorption of anti-Tpre  by  H-2-primed lymph node cells,  KLH-TNP-primed cells,  or 
thymocytes from the C.AL-20 animal.  107 CAL.B spleen cells were injected into C.AL-20 mice i.p. 
on day 10, and 10  7 C.AL.B cells were injected into the footpad on day 4. Lymph node cells from the 
popliteal node (,) were used to adsorb 40/~1 of tissue culture supernatant thymocytes. Alternatively, 
popliteal  nodes from C.AL-20  mice challenged on day -28  and -4  in the  footpads with 50/tg of 
KLH-TNP in CFA were used to adsorb antibody  (0).  C.AL-20  thymocytes (A)  were used as a 
positive control for adsorption. 
TABLE  III 
Tpre Is Expressed on Both Cortisone-Sensitive and Cortisone-resistant Adult 
Thymocytes 
Antibody  Comple-  Cortisone-  Control 
ment  treated* 
--  +  5+1:~  4+1 
Anti-Tpre  d  +  24 __ 6  30 ±  3 
Anti-Thy-l.2  +  33 ±  1  86 ±  1 
* As previously reported (17), ~20% of thymocytes in the C.AL-20 animal are 
resistant to 50 p.g of cortisone phosphate at 48 h. 
Data are expressed as percent dead cells  in duplicate determinations _  SE 
of  the  arithmetic  mean.  Antibody  from  tissue  culture  supernatant  was 
incubated with cells, complement was added, and eosin red was added to aid 
in visualization of dead cells under phase-contrast microscopy. 424  Tpre,  A  NEW  ALLOANTIGEN 
TABLE  IV 
Adult  Thymocytes Express Tthy a and  Tpre  d on Overlapping Populations 
Antibody  Comple-  Cytotoxic 
ment  index* 
Anti-Tthy  d (20/d)  +  anti-Tpre (20/11)  +  16 +  2 
Anti-Tthy  a (20/tl, clone 17IIC6)  +  13 +  1 
Anti-Tthy  a (40/LI, clone 17IIC6)  +  13 +  2 
Anti-Tpre  d (20 #l, clone F.6.9.1)  +  15 +  2 
Anti-Tpre  d (40/~1, clone F.6.9.1)  +  12 +  1 
Anti-Tthy  a (20/fl, clone 17IIC6) and anti-Tthy  d (20 p.l,  +  19 +  1 
clone 208IE6) 
Anti-Thy 1.2 (monoclonal)  +  69 +  2 
* Cytotoxic index is the number of dead cells in a given sample minus the number of 
dead cells in the complement control divided by the number of dead cells in the 
anti-theta  control  minus  the  dead  cells  in  the  complement  control  times  100. 
Complement killed 6% of the thymocytes. 
TABLE  g 
Tpre is Encoded by the IgT-C Region of Chromosome 12" 
Strain  Cytotoxic  index~:  Igh-V  Igh-C  IgT-C  H(Ig)  Pre 
BALB/c  < 1  a  a  a  0 
C.AL-20  30 +  5  d  d  d  d  a 
BAB/14  <1  a  b  b  b  c 
CB.AL- 1  < 1  d X  b  -  X  d  a 
C.B.AL-4  <1  d X  b  -  b  c 
* Visual lysis of adult  thymocytes by antibody  and  complement was  used to  type 
strains. 
See footnote, Table IV. 
TABLE  VI 
Expression  of Tpre on Adult C.AL-20 Bone Marrow 
Antibody  Treatment of adsorbing cells  Comple-  Cytotoxic 
ment  index* 
T-pre  --  +  18 +  3:~ 
T-pre  3 X  107 BM§ +  C']]  +  2 --- 4 
T-pre  1 ×  10  vBM+C'  +  7+2 
T-pre  5 ×  106 BM +  C'  +  14 +  1 
T-pre  107 Thy-l.2 BM +  C'  +  17 +  3 
T-pre  107 BAT¶ BM +  C'  +  21 +  5 
* See footnote, Table IV. 
:~ Antibody was used to lyse adult thymocytes from the C.AL-20 animal. 
§ Bone marrow. 
]1 Complement. 
¶ Brain-associated T  cell antigen. 
pattern  of Tpre  on  cells  in  the  bone  marrow  was  very  much  like  that  of  Tthy  (4) 
(Table  VI).  T  cells  sensitive  to  both  rabbit  anti-brain-associated  T  cell  antigen  (14) 
and  anti-Thy-l.2  (16)  bear  Tpre.  This  was  surprising  inasmuch  as  the  pre-T  cell  in 
marrow,  which  can  repopulate  the  thymus  of irradiated  recipients,  is  reported  to  be 
Thy-l.2  surface  negative  (15).  It  seemed  possible  that  many  T  cell  precursors  exist in FRANCES  L.  OWEN  425 
TABLE  VII 
Repopulation of Mouse Thymus in Irradiated Recipients with Adult Bone 
Marrow; Surface Phenotype of the Repopulating Cell 
Antibody*  Cells trans- 
Cells recovered at  10 d  in  Group  pretreatment  ferred/recipi- 
of marrow  ent~  recipient thymus§ 
1  None  1.5 X 10  7  7.9 X 10  6 +_ 4.6 ×  10  6 
2  None  None  2 X 10  4 
3  Anti-Thy-l.2  1.5 ×  10  7  18 ×  10  6:1:6 X 10  6 
4  Anti-Tthy  d  1.5 X  10  7  9.2 ×  10  6 +  3.0 ×  10  6 
5  Anti-Tpre  d  1.5 X  10  7  4,8 X  10  4 ±  2.8 ×  10  4 
* Syngeneic marrow was treated with  l  #g of monoclonal antibody per  1.5 × 
107 cells for 30 rain  at 4°C.  Cells  in  antibody were injected  intravenously 
into  recipients  I  h  after irradiation with  760 rad  137Cs.  All  antibodies  are 
IgM K monoclonals. 
:~ Cells were transferred intravenously. 
§ Four animals were used. Data represent the arithmetic mean ± SEM of three 
separate surviving mice/group, not pooled cells from three mice. The exper- 
iment was terminated on day 10 due to mortality and morbidity in groups 
2 and 5. 
marrow and that the Tpre-bearing cell was not identical to that previously described 
(15). This was pursued experimentally (Table VII). 
The data in Table VII show that a  cell in C.AL-20 marrow, which expresses Tpre, 
is capable of repopulating the thymus of lethally irradiated recipients. Marrow from 
C.AL-20  animals  was  incubated  with  monoclonal  anti-Tthy,  anti-Tpre,  or  anti- 
Thyl.2.  The  normal  marrow  repopulated the thymus  of syngeneic animals  treated 
with  760  rad  of gamma  radiation,  as  did  the  anti-Thy-l.2-  and  anti-Tthy-treated 
groups. In contrast, pretreatment of marrow with anti-Tpre resulted in no repopula- 
tion  (group  5)  in  contrast  to  the  untreated  irradiated animals  (group  2).  Group  5 
showed evidence of morbidity. The survival rate in groups 1-5 was 75%; the untreated 
animals (75% in group 2) died within  10 d. Our results agree with those of Basch and 
Kadish (15), who show that the repopulating cell is Thy-1.2 surface negative. 
Expresseion of Tpre in the AKR nuStr/nu str.  Limiting dilutions of cells from the AKR 
nuStr/nu ~t~  (17)  or AKR  +/nu ~tr age- and  sex-matched  animals were  used  to adsorb 
anti-Tpre.  The  residual  antibody was  then  scored  on  thymocytes  from  a  C.AL-20 
adult male mouse. The AKR nu~t'/nu~t~  bone marrow cells adsorbed at least  10 times 
less antibody than did bone marrow cells from the heterozygous +/nu st~ animal (Fig. 
2). The patterns of adsorption by spleen cells from heterozygote and homozygote are 
almost identical. This experiment was performed three times. In two experiments, 106 
marrow  cells adsorbed  50%  of the  amount  possible  (data not  shown).  We  did not 
perform additional experiments because large numbers of nudes were not  available. 
Earlier studies had shown that nu~t~/nu ~tr marrow cells do not express Tthy  (4). The 
defect  in  nu~t~/nu ~t~ animals  may  prevent  maturation  of a  common  precursor  to  a 
daughter cell destined to express Tthy in +/nu st~ animals. The nature of the defect is 
unknown.  Because  the  experiments  summarized  in  Table  VII  suggest  the  Tpre  + 
Tthy  + cell in marrow may be missing in nude mice, the frequency of Tpre  + cells was 
of critical interest. Attempts to estimate that frequency with antibody and complement 
failed  because  of complement  backgrounds  in  marrow.  The  following  alternative 
approach was taken. 426  Tpre, A  NEW  ALLOANTIGEN 
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Distribution  of Tpre,  Tthy,  Tind, and Tsu on Hybrids of nu *t~/nu ~tr or +/nu ~tr Bone Marrow 
Cells and BW5147.  Hybrids of BW5147  (AKR) and AKR  +/nu~t~/nu~tr  were grown. 
The  number  of growth-positive clones  per  marrow  cell  was  identical  for  the  two 
groups (14 clones per 5 X  l0  G  cells), and one assumes that the fusions were comparable. 
These lines were typed with antibody and complement for surface expression of Tpre, 
Tthy, Tind, and Tsu. It is possible that AKR  BW5147 may have a preferential fusion 
partner and that the state of differentiation of a given cell restricts its ability to stably 
fuse with the thymoma. Therefore, the lines developed may not be a random sampling 
of bone marrow.  It is, however, apparent that the two groups of lines, which should 
be closely related, differ with respect to surface expression of Tpre (Table VIII). The 
only surface phenotype in the nude lines is Tpre +, Tthy-, in contrast to the +/nu lines 
which  show  only Tpre  +,  Tthy  +.  Given  that  our  sample  size  is  small  and  that  the 
number  of lines  that  show  any  surface  positive  markers  is  smaller,  the  difference 
between  the  two  groups  is  striking.  This  is  consistent  with  a  model  in  which  the 
marrow  cell in nude  mice expresses Tpre  and  the Tpre +, Tthy  +, Thy-l.2  + cell that 
occurs  in  the heterozygote is either missing or very infrequent  in  the nude  animal. 
The  frequency of Tpre-positive cells in  these lines is 50-75%  for the cells from  the 
nude mouse and  10-15% for the heterozygous lines. The density per cell of Tpre may 
be very different, explaining the greater efficiency of adsorption by marrow from nude 
animals shown in Fig. 2. 
Distribution  of  Tpre  on  Antigen-Activated  Lymph  Node  Cells.  Tpre  is  expressed  on 
FIG. 2.  Cells from AKR nu~t~/nu~tr bone marrow adsorb anti-Tpre.  Limiting dilutions of marrow 
(Q) or spleen cells (If)  from nu~t~/nu  8tr or +/nu ~tr animals adsorb F.6.9.1. Residual antibody was 
scored on C.AL-20 adult thymocytes. Data are expressed on the basis of a cytotoxic index. The grey 
areas indicate the range of the cytotoxic index for unabsorbed antibody. FRANCES  L.  OWEN 
TABLE VIII 
Expression of Tpre,  Tthy, Tind,  and Tsu* on Hybrids  Originating from AKR 
nuStr/nuStr or +/nu 8tr Bone Marrow 
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nuStr / nu  sir  -t-/nu str 
Tpre  Tthy  Tind  Tsu  Tpre  Tt@  Tind  Tsu 
A1 
A5  + 
A3  + 
B6 
B1 
B4 
CI 
B3  + 
A6  + 
B5 
B2 
--  i 
m 
_  m 
R 
B 
m 
B6  +  + 
B4  -  - 
C1  +  + 
A2  +  + 
C2  -  + 
At  +  + 
A5  +  + 
B2  -  - 
B3  -  - 
B 
D 
m 
m 
B 
D 
D 
* Surface phenotype of each line was determined by visual cytotoxicity  using fluores- 
cein isothiocyanate-modified monoclonal antibodies. Greater than  10% lysis above 
a complement background of 5% was considered significant.  The lines from nu/nu 
animals were 30-50% positive for Tpre. 
TABLE  IX 
Depletion of Tpre in Mice Neonatally  Treated with Anti-Tthy 
Mouse  Comple-  Anti-Tthy-  Anti-Tthy  Anti-Tpre 
ment  1.2 
Control  8 ±  2*  48 ±  2  19 +  1  20 ±  1 
Experimental 1  7 ±  2  50 ±  5  9 +  1  8 ±  1 
Experimental 2  12 ±  1  43 ±  1  9 -  1  7 ±  1 
* Percent lysis of adult thymocytes. 
TABLE  X 
Expression of Tpre on l 7-d Fetal Thymocytes 
Anti-Tpre  Anti-Tthy  Anti-Tthy-  Comple- 
1.2  ment 
Day fetal cells  35 ±  5*  15 ±  4  43 ±  5  ll ±  3 
Adult cells  28 ±  1  31  ±  5  59:1:8  16 ±  4 
* Percent lysis with antibody and complement ±  SE of duplicate determina- 
tions. The Thy-l.2 control is unusually low in the adult. Two other experi- 
ments were completed with similar results  but  greater scattering of data 
points. 
keyhole limpet hemocyanin-trinitrophenyl hapten (KLH-TNP)-activated  lymph node 
cells with a  frequency and/or  density equal to that of the thymocyte pool (Fig. 2). In 
contrast, virgin lymph node cells and H-2b-stimulated lymph node cells do not express 
Tpre  in  detectable amounts  (Fig.  1).  These studies were performed by  quantitative 
adsorption. Tissue culture supernatant  from F.6.9.1  was adsorbed with  1  ×  106-3  × 
107 cells from the popliteal lymph node of mice treated on days -10  and -4  with 50 
#g of KLH-TNP  in complete Freund's adjuvant. Alternatively, node cells of C.AL-20 428  Tpre, A NEW ALLOANTIGEN 
(H-2  a)  mice challenged with  107 spleen cells from C.AL.B  (H-2  b)  mice on days -10 
and  -4  also  failed  to  adsorb  anti-Tpre  with  a  frequency  higher  than  that  of the 
resting cell population. Tpre is not detectable on the peripheral population by these 
assays. 
Coexpression of Tthy and Tpre on Overlapping Populations in the Adult.  We have devel- 
oped  a  model  for  in  vivo  depletion  of cells  expressing  Tthy. 3  Briefly  described, 
neonatal mice are injected with anti-Tthy on days 0-1 and at 3-d intervals thereafter 
until  they reach maturity. These animals fail to express cells having Tthy, Tind, or 
Tsu.  When  tested  with  antibody  and  complement,  the  Tpre-bearing  cell  is  also 
depleted  (Table IX). 
Expression of Tpre on Fetal Thymocytes.  Thymocytes were removed microscopically 
from 17-d fetal animals. Cells (1  ×  l0  s) were treated with anti-Tpre or anti-Tthy and 
complement. Anti-Tpre lyses a detectable number (25%) of fetal thymocytes, whereas 
anti-Tthy does not  (Table X). Adult  thymocytes express both Tpre and Tthy. Fetal 
liver cells do not express Tpre on day 13,  15, or 17 with a frequency/density detectable 
by direct lysis in this assay (data not shown). A  more extensive fetal ontogeny study 
is in progress. 
Discussion 
A  series of four T  cell aIloantigens, encoded within  a  short region of chromosome 
12, have been described. Tpre, Tthy, Tind, and Tsu may be closely related products 
of a  family of genes coding for antigenic determinants on regulatory T  cells. These 
antigens  are expressed sequentially  in  ontogeny and  T  cell  maturation  (Table IX) 
(18).  The relationship of the cells expressing these alloantigens needs greater clarifi- 
cation.  It has been shown  that  the cell  that  expresses Tthy is  a  probable common 
precursor for those ceils expressing Tsu and Tind. 3 At  present  there is  no evidence 
that Tpre is expressed on a  precursor cell for the cell expressing Tthy, although this 
possibility is being explored. This cell does appear on or before day 17 in fetal thymus, 
before  the  appearance  of cells  expressing  Tthy.  Tpre  and  Tthy  are  expressed  on 
largely overlapping cells in  adult  thymus  (Tables  IV and  VIII). It  therefore is  not 
surprising  that  an  occasional  hybrid  T  cell  arising  from peripheral  node  expresses 
Tpre and Tthy simultaneously (Table II). 
It is possible that these antigens represent a  group of T  cell-specific antigen recep- 
tors  on  cells  that  regulate  immunoglobulin  synthesis,  If that  is  the  case,  a  gene 
complex with an evolutionary link to the immunoglobulin genes might be expected 
to observe some of the same biological and organizational rules. One might expect an 
ordered sequence of genes on the chromosome, with characteristic genetic rearrange- 
ment  mechanisms  to  conserve  antigen-binding  information;  an  adherence  to  the 
phenomenon  of allelic  exclusion  of genes  on  the  chromosome,  with  characteristic 
genetic rearrangement mechanisms to conserve antigen-binding information; and the 
existence of characteristic switch sites between  gene segments. The immunoglobulin 
isotypes are distributed on B ceils at characteristic points in B cell maturation.  It is 
possible that T  cell "isotypes" are similarly distributed  and that Tpre, Tthy, Tind, 
and Tsu are the first four members of such a  family. 
The new alloantigen described in this paper, Tpre, is a separate antigenic specificity 
3  Keesee, S. K., and F. L. Owen. Neonatal modulation of Tthy. The cell bearing Tthy is required for the 
appearance of the cells expressing Tind and Tsu. J. Exp. Med. 157:86. FRANCES L. OWEN  429 
from that  previously described as Tthy (3).  Several lines of evidence establish  this 
difference: (a) Tpre is expressed on three fetal T  cell hybrids that do not express Tthy 
(Table I, lines FTT 17-1,  FTT 17-3, and FTL 12-4)  and two adult hybrids that do 
not express Tthy (Table II, SKO 220 and SKO 230). An occasional hybrid (Table II, 
SKO 240 and SKO 208)  expresses Tthy and not Tpre. Many fetal and adult  lines 
express these two antigens simultaneously. (b) Only the Tpre antigen is expressed on 
hematopoietic precursors for thymic repopulation (Table VII) or on a  stem cell for 
the lymphoid lineage. Experiments to distinguish  these possibilities are in progress. 
Anti-Tpre depletes cells from normal adult  marrow capable of repopulation of the 
thymus in lethally irradiated adult mice. Anti-Tthy or anti-Thy-l.2 fail to do so.  (c) 
Tpre is expressed in nude mice, whereas Tthy is not (Fig. 1) (18).  (d) Tpre is expressed 
in fetal ontogeny before the expression of Tthy (Table IX).  Despite these apparent 
differences in cell distribution during hematopoiesis, there is considerable overlap in 
the cellular distribution of Tpre and Tthy in the adult  animal.  Cortisone-sensitive 
and  cortisone-resistant  populations  seem  to express these  antigens  with  equal  fre- 
quency (Table III). Sequential or simultaneous addition of anti-Tpre or anti-Tthy to 
thymocytes does  not  result  in  additive  lysis  of cells  (Table  IV).  Mice  neonatally 
maintained with anti-Tthy fail to express Tthy  3 and also fail to express Tpre (Table 
IX).  The  distribution  in  adult  bone  marrow  may  also  be  partially  overlapping. 
Treatment of bone marrow with anti-Tthy-l.2 and complement depletes cells that 
adsorb  both  anti-Tpre  (Table VI)  and  anti-Tthy  (17).  However, pretreatment  of 
marrow with anti-Tpre, Tthy, and Thy-l.2 shows only the cell that expresses Tpre 
independently  of Thy-l.2,  and  Tthy  is  the  hematopoietic  precursor  for  thymic 
repopulation (Table VII). This implies that there are two cells in marrow expressing 
Tpre; one expresses Tpre and the other Tpre and Thy-l.2, possibly with Tthy. This 
is consistent with a  model in which a  Tpre-bearing cell arises before maturation of 
Tthy. 
There is no direct evidence that Tpre is an antigen receptor on fetal cells (or any 
cell). The presence of such a receptor has been inferred from functional data showing 
that  19-d fetal liver contains precursor cells for alloreactive cytotoxic T  lymphocytes 
(8). Cells that can be sensitized to alloantigen and allowed to mature in embryonic 
organ culture exist earlier in ontogeny (19). For these reasons, it has been suggested 
that the alloreceptor may be the most primitive of the family of T  cell receptors (20). 
The ontological similarity in expression of Tpre and the receptor for alloantigen led 
to  experiments examining expression  of Tpre on  alloreactive cells  (Fig.  2).  Adult 
lymph node cells sensitized to H-2  b alloantigens do not express Tpre. A source of fetal 
T  cells sensitized to alloantigen was not available for study. It is possible that cells in 
the alloreactive pathway undergo isotype switching in maturation and that adult cells 
use  a  different  structure  than  fetal  cells.  There  is  no  evidence  at  present  for  a 
relationship between Tpre and the antigen receptor on any alloreactive cells or fetal 
cells. 
A  potential relationship between the cell that  expresses Tpre and  the pre-T cell 
described by others  (15,  19,  21,  22)  needs  further experimental clarification.  The 
presence of this cell in the marrow of nude animals does suggest that it is a prethymic 
cell. In addition, the brief data in Table VII showing thymic repopulation capability 
make this a potential candidate for the elusive pre-T cell. At present, the functional 
capability of the cells in nudes expressing this antigen is being pursued. If the cell that 430  Tpre, A NEW ALLOANTIGEN 
expresses Tpre is  a  direct  precursor of those  in  the  marrow that  express Tthy and 
those in the periphery expressing Tsu and Tind, then an arrest in migration of Tpre- 
bearing cells  from the marrow may be responsible for the absence of cells in  nude 
expressing Tthy, Tind, or Tsu  (18).  It is possible that  growth  factors under thymic 
influence  may be responsible  for maturation  of this  lineage  of cells  from a  single 
common precursor. 
The expression of adult antigens on both "T" hybrids and "B" hybrids from fetal 
liver (12-d)  was surprising (Table I). An ontogeny study (18)  had shown that Tthy, 
Tind,  and Tsu are expressed postnatally.  The fusion  partner for the hybrid cells is 
BW5147  (an  AKR  thymoma).  It  is  possible  that  the  adult  thymoma cell  has  the 
genetic information (Igh-1 a)  to complement the fetal cell and that the source of the 
adult antigens in the fetal hybrids is BW5147.  BW5147 does not express any of these 
antigens  on  the  surface  or  by  [~S]methionine  labeling  (unpublished  observation). 
Genetic complementation could explain the precocious appearance of these antigens 
on the surface of fetal cells but not the fact that two fetal liver T  cell lines express all 
four  antigens  simultaneously.  In  adult  hybrids  (18)  no  cells  expressing  all  these 
antigens  simultaneously appeared even though  the same thymoma was used as the 
fusion  partner.  In addition,  one line,  FBL  12-3,  expresses all  these  T  cell  antigens 
(and Thyl.2)  but  arose from P.3U1  (BALB/c chain  myeloma) fusion  to  12-d  fetal 
liver.  Transcomplementation  is  not  a  plausible  mechanism  for  surface  expression 
because  the  BALB/c  animal  has  the  Igh-1 a allotype;  at  the IgT-C region  they are 
Tthy  a.  This  suggests  there  may be  precursor  cells  in  fetal  liver that  are  not  fully 
committed and differentiated. Only hybrids arising from fetal liver show this anom- 
alous  expression.  This observation should  be pursued  at  a  molecular genetic  level, 
and  a  careful  fetal ontogeny study could  be informative. Because Tthy, Tind,  and 
Tsu are expressed postnatally, factors that influence maturation of functional T  cells 
may also be required for the maturation of cells bearing Tthy, Tind, and Tsu from a 
common precursor. The bridge from fetal to adult development in normal mice seems 
to be blocked at a stage very much like that observed in the AKR nu~t~/nu  8tr (Fig.  1), 
which lacks an immunocompetent thymus. Perhaps thymus-dependent polypeptides 
are  required  for  sequential  maturation  of  this  lineage  of  cells.  Growth  factors, 
including T  cell growth factor (23), may not be synthesized until postnatal develop- 
ment is complete. Although we have interpreted these data to imply that this series of 
four antigens represents antigen receptors, it is possible that they are differentiation 
antigens on regulatory cells and that similarities with the Ig products arise solely from 
an evolutionary relationship. 
Summary 
A new T cell alloantigen, Tpre, has been identified by monoclonal F.6.9.1 antibody. 
This antigen is encoded by a gene linked to the cluster of T  cell antigens in the IgT- 
C region of chromosome 12 (Tthy, Tind, and Tsu). Tpre is distinct from Tthy, Tind, 
or Tsu because it is expressed on bone marrow cells of the AKR nuSt~/nu~tr, the thymus 
repopulating precursor cell in  normal adult  marrow, and  normal  fetal thymocytes. 
Several fetal and adult T  cell hybrids express these antigens independently. Tpre and 
Tthy are expressed on largely overlapping cell populations in adult thymus. FRANCES L.  OWEN  431 
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